You are here

  • Home
  • Archive
  • Volume 10, Issue 5
  • Correction: Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept

Article metrics

Article menu

See original article:

Download PDFPDF

Correction
Correction: Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept

 

Online download statistics by month:

Online download statistics by month: May 2022 to October 2025

AbstractFullPdf
May 20220264
Jun 2022020334
Jul 202208714
Aug 202207810
Sep 202207130
Oct 202207617
Nov 20220543
Dec 20220537
Jan 20230394
Feb 202305213
Mar 20230287
Apr 20230116
May 20230148
Jun 20230192
Jul 20230209
Aug 20230154
Sep 20230164
Oct 20230179
Nov 20230216
Dec 202303110
Jan 20240206
Feb 20240205
Mar 202402149
Apr 202401814
May 20240217
Jun 20240187
Jul 20240234
Aug 20240257
Sep 20240229
Oct 20240229
Nov 20240246
Dec 20240337
Jan 20250253
Feb 20250114
Mar 20250154
Apr 20250345
May 20250175
Jun 20250217
Jul 2025010
Aug 2025010
Oct 2025050
Total01328359